Head-to-head · WeighScore
Bon Health vs Mint Med
By GLP-1 ScorecardUpdated
Score comparison
Mint Med has the higher recorded score — 78.7/100 to 69.7/100.
Mint Med grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Low both-molecule pricing ($117/$159) and verified — but only 36 states.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Bon Health | Mint Med |
|---|---|---|
| WeighScore | 69.7/100 | 78.7/100 |
| Grade | C | C+ |
| Site position | #128 | #45 |
| Semaglutide | $120/mo (12-month plan, compounded) | $117/mo |
| Tirzepatide | $170/mo (12-month plan, compounded) | $159/mo |
| Coverage | Coverage not published | 36 states |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #128 · C
Strengths
- Transparent commitment-tier pricing from $170/mo (annual) for compounded semaglutide and tirzepatide; $0 membership fee, cancel anytime
- Physician-led: comprehensive medical review and physician-titrated dosing, not a 2-minute quiz
- 24/7 physician support included free with your order; 1-3 day rapid dispatch
- Licensed in all 50 states; uses 503A & 503B compounding pharmacies; brand-name Wegovy/Ozempic/Zepbound/Mounjaro also offered
What to consider
- The advertised rates need a full year paid up front; billed monthly, semaglutide is $230 and the annual figure nearly doubles
- The brand-name pages are marketing, not products — every Wegovy, Ozempic, Zepbound and Mounjaro CTA reads 'Coming Soon' and points back to the compounded version
- Coverage is not published: a badge claims all 50 states while the weight-loss page says availability varies by state
- The terms page returns a 404, so the refund mechanics behind the prepaid 3-, 6- and 12-month tiers cannot be read
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
Site position #45 · C+
FDAWarning letter issued to Glow Medispa, LLC dba Mint Med in June 2026. See the FDA warning-letter database.
Strengths
- $117 sema / $159 tirz
- LegitScript-verified
- Both molecules
What to consider
- Only 36 states
- Injection-only
- Monitoring detail sparse
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.